{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:53:03Z","timestamp":1791406383252,"version":"4.3.3"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","worldneurosurgery.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.wneu.2017.03.058","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T18:44:15Z","timestamp":1490294655000},"page":"113-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Transforming Growth Factor Beta Family in the Pathogenesis of Meningiomas"],"prefix":"10.1016","volume":"104","author":[{"given":"Mahlon D.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2017.03.058_bib1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","article-title":"Pathological classification and molecular genetics of meningiomas","volume":"99","author":"Mawrin","year":"2010","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2017.03.058_bib2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1227\/NEU.0000000000000633","article-title":"Stereotactic radiosurgery for intracranial meningiomas: current concepts and future perspectives","volume":"76","author":"Mansouri","year":"2015","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2017.03.058_bib3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/CCO.0b013e328356364d","article-title":"The role of chemotherapy and targeted therapy in treatment of intracranial meningioma","volume":"24","author":"Chamberlain","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.wneu.2017.03.058_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fsurg.2016.00040","article-title":"Meningioma genomics: diagnostic, prognostic and therapeutic applications","volume":"3","author":"Bi","year":"2016","journal-title":"Front Surg"},{"key":"10.1016\/j.wneu.2017.03.058_bib5","first-page":"79","article-title":"The cell biology of transforming growth factor B","volume":"1032","author":"Barnard","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.wneu.2017.03.058_bib6","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.biocel.2007.11.026","article-title":"The role of proteases in transforming growth factor-B activation","volume":"40","author":"Jenkins","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.wneu.2017.03.058_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jcb.21501","article-title":"TGF-\u03b2 signaling: a tale of two responses","volume":"102","author":"Rahimi","year":"2007","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.wneu.2017.03.058_bib8","doi-asserted-by":"crossref","first-page":"a021899","DOI":"10.1101\/cshperspect.a021899","article-title":"Bone morphogenetic proteins","volume":"8","author":"Katagri","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.wneu.2017.03.058_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cancergen.2012.05.009","article-title":"Bone morphogenetic protein 4\u2014a fascinating regulator of cancer cell behavior","volume":"205","author":"Kallioniemi","year":"2012","journal-title":"Cancer Genet"},{"key":"10.1016\/j.wneu.2017.03.058_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/383168a0","article-title":"Receptor associated Mad homologues synergize as effectors of the TGF-\u03b2 response","volume":"383","author":"Zhang","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2017.03.058_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1615\/CritRevEukarGeneExpr.v17.i4.30","article-title":"Roles of Smad3 in TGF-\u03b2 signaling during carcinogenesis","volume":"17","author":"Millet","year":"2007","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.wneu.2017.03.058_bib12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2017.03.058_bib13","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1038\/sj.onc.1208928","article-title":"Cross talk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis","volume":"24","author":"Javelaud","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.wneu.2017.03.058_bib14","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.1016\/S0021-9258(17)36823-0","article-title":"Two different signal transduction pathways can be activated by transforming growth factor \u03b21 in epithelial cells","volume":"269","author":"Yan","year":"1994","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.wneu.2017.03.058_bib15","doi-asserted-by":"crossref","first-page":"16567","DOI":"10.1074\/jbc.271.28.16567","article-title":"Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-B1 on gene expression","volume":"271","author":"Mucsi","year":"1996","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.wneu.2017.03.058_bib16","first-page":"628","article-title":"Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase\/Jun N-terminal kinase activation by transforming growth factor B in negative growth control of breast cancer cells","volume":"57","author":"Frey","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2017.03.058_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0065-230X(08)60765-4","article-title":"Signal transduction through MAP kinase cascades","volume":"74","author":"Lewis","year":"1998","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.wneu.2017.03.058_bib18","doi-asserted-by":"crossref","first-page":"29628","DOI":"10.1074\/jbc.270.50.29628","article-title":"Interaction of the transforming growth factor-\u03b2 type 1 receptor with farnesyl-protein transferase-\u03b1","volume":"270","author":"Kawabata","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.wneu.2017.03.058_bib19","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1161\/01.ATV.19.9.2127","article-title":"PI3K","volume":"19","author":"Higaki","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.wneu.2017.03.058_bib20","doi-asserted-by":"crossref","first-page":"36803","DOI":"10.1074\/jbc.M005912200","article-title":"Phosphatidylinositol 3-kinase function is required for transforming growth factor B-mediated epithelial to mesenchymal transition and cell migration","volume":"275","author":"Bakin","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.wneu.2017.03.058_bib21","first-page":"381","article-title":"The phosphatidylinositol 3-kinase\u2013AKT pathway in human cancer","volume":"14","author":"Vivanco","year":"2002","journal-title":"Cell Signal"},{"key":"10.1016\/j.wneu.2017.03.058_bib22","doi-asserted-by":"crossref","first-page":"37292","DOI":"10.1074\/jbc.274.52.37292","article-title":"Induction of collagenase-3 (MMP-13) expression in human skip fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase","volume":"274","author":"Ravanti","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.wneu.2017.03.058_bib23","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.urology.2010.03.061","article-title":"Overexpression of transforming growth factor beta 1 in malignant prostate cells is partly caused by a runaway of TGF-beta1 auto-induction mediated through a defective recruitment of protein phosphatase 2a by TGF-beta type I receptor","volume":"76","author":"Yu","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.wneu.2017.03.058_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cytogfr.2005.01.009","article-title":"BMP receptor signaling: transcriptional targets, regulation of signals and signaling cross-talk","volume":"16","author":"Miyazono","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.wneu.2017.03.058_bib25","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1111\/j.1742-4658.2007.05840.x","article-title":"Cross-talk between the bone morphogenic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes","volume":"274","author":"Herpin","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.wneu.2017.03.058_bib26","doi-asserted-by":"crossref","first-page":"L370","DOI":"10.1152\/ajplung.00242.2004","article-title":"BMP4 inhibits proliferation and promotes myocyte differentiation of lung fibroblasts via Smad1 and JNK pathways","volume":"288","author":"Jeffrey","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.wneu.2017.03.058_bib27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.cellsig.2007.01.017","article-title":"BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS\/ERK","volume":"19","author":"Beck","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.wneu.2017.03.058_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGF-B in cancer","volume":"134","author":"Massague","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2017.03.058_bib29","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1165\/rcmb.2006-0360OC","article-title":"BMP induces HO-1 via Smad-independent, p38MAPK-dependent pathway in pulmonary artery myocytes","volume":"37","author":"Yang","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.wneu.2017.03.058_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neulet.2015.08.028","article-title":"Bone morphogenetic protein-4 and 7 and receptors regulate vascular endothelial growth factor and receptors in human fetal leptomeninges","volume":"606","author":"Johnson","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.wneu.2017.03.058_bib31","first-page":"1","article-title":"Transforming growth factor-\u03b2 superfamily in meningiomas: targets for novel therapy in meningiomas?","volume":"3","author":"Johnson","year":"2015","journal-title":"Int J Neuropathol"},{"key":"10.1016\/j.wneu.2017.03.058_bib32","first-page":"631","article-title":"Transforming growth factor-\u03b2 and transforming growth factor-\u03b2 receptor expression in human meningioma cells","volume":"141","author":"Johnson","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.wneu.2017.03.058_bib33","first-page":"360","article-title":"Evidence for TGF-\u03b2 expression in human leptomeningeal cells and TGF-\u03b2-like activity in human cerebrospinal fluid","volume":"67","author":"Johnson","year":"1992","journal-title":"Lab Invest"},{"key":"10.1016\/j.wneu.2017.03.058_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/B:NEON.0000013461.35120.8a","article-title":"Transforming growth factor-\u03b2 effects on meningioma cell proliferation and signal transduction pathways","volume":"66","author":"Johnson","year":"2004","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2017.03.058_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11060-010-0399-y","article-title":"Analysis of transforming growth factor \u03b2 receptor expression and signaling in higher grade meningiomas","volume":"103","author":"Johnson","year":"2001","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2017.03.058_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1476-4598-6-64","article-title":"Molecular signatures define two main classes of meningiomas","volume":"6","author":"Carvalho","year":"2007","journal-title":"Mol Cancer"},{"key":"10.1016\/j.wneu.2017.03.058_bib37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3171\/jns.2001.94.2.0293","article-title":"Evidence for mitogen associated protein kinase activation and transduction of mitogenic signals from platelet derived growth factor in human meningioma cells","volume":"94","author":"Johnson","year":"2001","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.03.058_bib38","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1158\/1078-0432.CCR-04-2550","article-title":"Different activation of mitogen activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas","volume":"11","author":"Mawrin","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2017.03.058_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3727\/095535489820875327","article-title":"Clonal stimulation or inhibition of human colon carcinomas and human renal carcinomas mediated by transforming growth factor-beta 1","volume":"1","author":"Fan","year":"1989","journal-title":"Cancer Commun"},{"key":"10.1016\/j.wneu.2017.03.058_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijc.2910490124","article-title":"TGF-\u03b2 1 and TGF-\u03b2 2 are potential growth regulators for low grade and malignant gliomas in\u00a0vitro: evidence in support of an autocrine hypothesis","volume":"49","author":"Jennings","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.wneu.2017.03.058_bib41","first-page":"1471","article-title":"Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta","volume":"6","author":"Manning","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.wneu.2017.03.058_bib42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jnci\/djt369","article-title":"TGF-B: Duality of function between tumor prevention and carcinogenesis","volume":"106","author":"Principe","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.wneu.2017.03.058_bib43","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1101\/gad.8.20.2429","article-title":"Targeted deletion of the TGF-beta gene causes rapid progression to squamous cell carcinoma","volume":"8","author":"Glick","year":"1994","journal-title":"Genes Dev"},{"key":"10.1016\/j.wneu.2017.03.058_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0027-5107(01)00157-9","article-title":"Analysis for TGF-beta type I receptor for mutations in polymorphisms in head and neck cancers","volume":"479","author":"Knobloch","year":"2001","journal-title":"Mutat Res"},{"key":"10.1016\/j.wneu.2017.03.058_bib45","first-page":"4805","article-title":"Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer","volume":"58","author":"Chen","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2017.03.058_bib46","first-page":"4679","article-title":"Transforming growth factor beta type I receptor gene is frequently mutated in ovarian carcinomas","volume":"61","author":"Chen","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2017.03.058_bib47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00432-007-0290-1","article-title":"TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in the Chinese population","volume":"134","author":"Jin","year":"2008","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.wneu.2017.03.058_bib48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/bcr42","article-title":"Transforming growth factor-B and breast cancer. Transforming growth factor-B\/SMAD signaling defects and cancer","volume":"2","author":"Kretzschmar","year":"2000","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.wneu.2017.03.058_bib49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/(SICI)1097-0215(19961009)68:2<203::AID-IJC11>3.0.CO;2-B","article-title":"Mutations of the transforming growth factor receptor type II receptor gene and microsatellite instability in gastric cancer","volume":"68","author":"Ohue","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.wneu.2017.03.058_bib50","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/gcc.20400","article-title":"Novel microdeletion in the transforming growth factor beta type II receptor gene is associated with giant and large cell variants of nonsmall cell lung carcinoma","volume":"26","author":"Wang","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.wneu.2017.03.058_bib51","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1093\/hmg\/ddl486","article-title":"TGF-B signaling alterations and susceptibility to colorectal cancer","volume":"16","author":"Xu","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.wneu.2017.03.058_bib52","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1038\/sj.onc.1206835","article-title":"Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression","volume":"22","author":"Copland","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.wneu.2017.03.058_bib53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1530\/eje.1.01849","article-title":"Inhibin alpha subunit and the inhibin co-receptor betaglycan are downregulated in endometrial carcinoma","volume":"152","author":"Florio","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2017.03.058_bib54","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1158\/0008-5472.CAN-07-0035","article-title":"Loss of betaglycan expression in ovarian cancer: role in motility and invasion","volume":"67","author":"Hempel","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2017.03.058_bib55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/me.2008-0300","article-title":"Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells","volume":"23","author":"Bilandzic","year":"2009","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.wneu.2017.03.058_bib56","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1054\/bjoc.1999.1058","article-title":"Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas","volume":"82","author":"Iolascon","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.wneu.2017.03.058_bib57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/pros.20526","article-title":"TGFBR3 loss and consequences in prostate cancer","volume":"67","author":"Sharifi","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.wneu.2017.03.058_bib58","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1158\/0008-5472.CAN-06-3117","article-title":"The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer","volume":"67","author":"Turley","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2017.03.058_bib59","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/carcin\/bgm289","article-title":"TGFbeta RIII suppresses non-small cell lung cancer invasiveness and tumorigenicity","volume":"29","author":"Finger","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.wneu.2017.03.058_bib60","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1172\/JCI29293","article-title":"The type III TGF-beta receptor suppresses breast cancer progression","volume":"17","author":"Dong","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.wneu.2017.03.058_bib61","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fonc.2014.00094","article-title":"Mysteries of TGF-B paradox in benign and malignant cells","volume":"4","author":"Zhang","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2017.03.058_bib62","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/NEN.0b013e3181bc6642","article-title":"Bone morphogenetic protein-4 and receptors are expressed in the leptomeninges and meningiomas and signal via MAPK","volume":"68","author":"Johnson","year":"2009","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.wneu.2017.03.058_bib63","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","article-title":"Histological classification and molecular genetics of meningiomas","volume":"5","author":"Riemenschneider","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2017.03.058_bib64","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1182\/blood.V97.2.516","article-title":"Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells","volume":"97","author":"Hiertner","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2017.03.058_bib65","doi-asserted-by":"crossref","first-page":"L81","DOI":"10.1152\/ajplung.00160.2003","article-title":"BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells","volume":"286","author":"Buckley","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.wneu.2017.03.058_bib66","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10549-010-0808-0","article-title":"Parallel inhibition of cell growth and induction of cell migration and invasion of breast cancer cells by bone morphogenetic protein 4","volume":"124","author":"Ketolainen","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.wneu.2017.03.058_bib67","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.yexcr.2011.06.001","article-title":"Bone morphogenetic protein-4 and -5 in pancreatic cancer-novel bidirectional players","volume":"317","author":"Virtanen","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.wneu.2017.03.058_bib68","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2009.02.046","article-title":"Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells","volume":"281","author":"Deng","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.wneu.2017.03.058_bib69","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ng.262","article-title":"Meta-analysis of genome-wide association with data identifies four new susceptibility loci for colorectal cancer","volume":"40","author":"Houlston","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.wneu.2017.03.058_bib70","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1038\/onc.2011.564","article-title":"The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4","volume":"31","author":"Lubbe","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.wneu.2017.03.058_bib71","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ijc.26047","article-title":"Genetic variation in bone morphogenetic protein and colon and rectal cancer","volume":"130","author":"Slattery","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.wneu.2017.03.058_bib72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/cbr.2010.0857","article-title":"Bone morphogenetic protein 4 inhibits cell proliferation and induces cell apoptosis in glioma stem cells","volume":"26","author":"Zhou","year":"2011","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.wneu.2017.03.058_bib73","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/(SICI)1097-4547(19990501)56:3<248::AID-JNR4>3.0.CO;2-U","article-title":"Bone morphogenetic proteins-2 and -4 attenuate apoptosis in a cerebellar primitive neuroectodermal tumor cell line","volume":"56","author":"Intosca","year":"1999","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.wneu.2017.03.058_bib74","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1073\/pnas.0237312100","article-title":"Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad\/estrogen receptor crosstalk","volume":"100","author":"Paez-Pereda","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.wneu.2017.03.058_bib75","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbrc.2008.07.007","article-title":"Bone morphogenic protein-4 strongly potentiates growth factor-induced proliferation of mammary epithelial cells","volume":"374","author":"Montesano","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.wneu.2017.03.058_bib76","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/39369","article-title":"Identification of Smad 7 a TGF-\u03b2 inducible antagonist of TGF-\u03b2 signaling","volume":"389","author":"Nakano","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2017.03.058_bib77","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/BF03345213","article-title":"Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines","volume":"26","author":"Cerutti","year":"2003","journal-title":"J\u00a0Endocrinol Invest"},{"key":"10.1016\/j.wneu.2017.03.058_bib78","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2004.10.006","article-title":"Overexpression of the TGF-beta antagonist Smad 7 in endometrial cancer","volume":"96","author":"Dowdy","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.wneu.2017.03.058_bib79","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11060-004-2749-0","article-title":"Molecular pathogenesis of meningiomas","volume":"70","author":"Perry","year":"2004","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2017.03.058_bib80","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/Merlin is a novel negative regulator of mTOR complex1 and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"8","author":"James","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.wneu.2017.03.058_bib81","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jocn.2016.03.014","article-title":"Review of controversies in management of non-benign meningioma","volume":"31","author":"Paldor","year":"2016","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2017.03.058_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-014-1620-1","article-title":"Atypical meningioma: current management dilemmas and prospective clinical trials","volume":"121","author":"Jenkinson","year":"2015","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2017.03.058_bib83","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3171\/jns.1991.74.6.0861","article-title":"Treatment of unresectable meningiomas with the anti-progesterone agent mifepristone","volume":"74","author":"Grunberg","year":"1991","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.03.058_bib84","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/07357900601062339","article-title":"Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma","volume":"24","author":"Grunberg","year":"2006","journal-title":"Cancer Invest"},{"key":"10.1016\/j.wneu.2017.03.058_bib85","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11060-011-0741-z","article-title":"Hydroxyurea for recurrent and radiation refractory high grade meningiomas","volume":"107","author":"Chamberlain","year":"2012","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2017.03.058_bib86","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2217\/cns.13.17","article-title":"IFN-\u03b1 for recurrent surgery- and radiation refractory high-grade meningioma: a retrospective case series","volume":"2","author":"Chamberlain","year":"2013","journal-title":"CNS Oncol"},{"key":"10.1016\/j.wneu.2017.03.058_bib87","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00280-014-2422-z","article-title":"Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy","volume":"73","author":"Simo","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.wneu.2017.03.058_bib88","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11060-012-0886-4","article-title":"Atypical and anaplastic meningiomas treated with bevacizumab","volume":"109","author":"Nayak","year":"2012","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2017.03.058_bib89","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/neuonc\/nou148","article-title":"Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma","volume":"17","author":"Kaley","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2017.03.058_bib90","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1158\/1078-0432.CCR-14-1380","article-title":"First-in-human dose study of the novel transforming growth factor-B receptor 1 kinase inhibitor LY 2157299 monohydrate in patients with advanced cancer and glioma","volume":"21","author":"Rodon","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.wneu.2017.03.058_bib91","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.semnephrol.2012.04.008","article-title":"Retinoid and TGF-B families: crosstalk in development, neoplasia, immunity and tissue repair","volume":"32","author":"Xu","year":"2012","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.wneu.2017.03.058_bib92","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/ncb2861","article-title":"TGF-\u03b2 2 dictates disseminated tumor cell fate in target organs through TGF-\u03b2 RIII and p38a.B signaling","volume":"15","author":"Bragado","year":"2013","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.wneu.2017.03.058_bib93","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.semradonc.2013.05.001","article-title":"Tumors as organs: biologically augmented radiation therapy by inhibiting TGF-\u03b2 actions in carcinomas","volume":"23","author":"Du","year":"2013","journal-title":"Semin Radiat Oncol"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017303819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017303819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T19:54:23Z","timestamp":1692734063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875017303819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":93,"alternative-id":["S1878875017303819"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2017.03.058","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transforming Growth Factor Beta Family in the Pathogenesis of Meningiomas","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2017.03.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}